We are dedicated to developing therapeutic molecules that overcome foundational barriers that prevent patients from living longer, cancer-free lives.
We recognize cancer as a chronic disease and are focused on developing therapies that address the most common cause of cancer mortality: relapse and metastasis. We believe treatments focused on modulating the foundational barriers that allow treatment-resistant cancer cells to reawaken as relapse and metastasis will meaningfully impact patient outcomes.
We believe that overcoming foundational barriers requires collaboration of vision, scientific rigor, novel approaches and bold thought-leaders who are devoted to a shared mission.
Explore our company updates and news to learn more about how we are overcoming barriers in cancer.
Every day at HiberCell moves us closer to a world in which cancer doesn’t win. If you share this passion, there may be a role for you on our team.
We are proud to be supported by some of the world’s most visionary investors in biotechnology.